Giulia Fornasa, PhD

European institute of oncology
European Institute of Oncology
via Adamello 16
Milan Italy 20139

Any personal financial relationships? No

I have not and will not accept any additional honoraria, payments or reimbursements beyond that which has been agreed upon directly with ICMI.

1. I will insure balance, independence, objectivity, and scientific rigor in my role in the planning, development or presentation of this CME activity.

2. I will comply with the requirements to protect health information under the Health Insurance Portability & Accountability Act of 1996 (HIPAA).

3. I will disclose any discussion or reference to unapproved or unlabeled uses of therapeutic agents or products.

4. I have input my full name below as attestation of agreement with declaration statements. Marking the check box and indicating my name is in lieu of signature and is considered an "e-signature".

Signed on 02/11/2015 by Giulia Fornasa

Papers:
T.96 The differential role of Thymic stromal lymphopoietin (TSLP) isoforms in intestinal and skin pathologies
W.5 Lack of Thymic Stromal Lymphopoietin (TSLP) Down-Regulation of Mucosal Pro-Inflammatory Cytokines in Refractory Coeliac Disease (CD)

	I have not and will not accept any additional honoraria, payments or reimbursements beyond that which has been agreed upon directly with ICMI.
	1. I will insure balance, independence, objectivity, and scientific rigor in my role in the planning, development or presentation of this CME activity.
	2. I will comply with the requirements to protect health information under the Health Insurance Portability & Accountability Act of 1996 (HIPAA).
	3. I will disclose any discussion or reference to unapproved or unlabeled uses of therapeutic agents or products.
	4. I have input my full name below as attestation of agreement with declaration statements. Marking the check box and indicating my name is in lieu of signature and is considered an "e-signature".